These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3698130)

  • 1. Comparison of the effects of feprazone and phenylbutazone on testosterone hydroxylations in mouse hepatic microsomes.
    Morita K; Hayashi Y; Ono T; Shimakawa H
    Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):214-20. PubMed ID: 3698130
    [No Abstract]   [Full Text] [Related]  

  • 2. Inducing effect of feprazone on hepatic drug-metabolizing enzymes in man.
    Morita K; Shibata H; Ono T; Shimakawa H
    Eur J Clin Pharmacol; 1986; 31(1):117-8. PubMed ID: 3780819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feprazone: an inducer of the P450 II B family of proteins in the rat.
    Smith JN; Ayrton AD; Chown J; Lewis DF; Ioannides C
    J Biochem Toxicol; 1990; 5(1):9-12. PubMed ID: 2402005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects.
    Meloni T; Forteleoni G; Serra M; Daniotti S; Negri L; Giuntini P; Canepa L; Gaetani GF
    J Clin Pharmacol; 1982; 22(8-9):418-20. PubMed ID: 7130431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in the metabolism of feprazone, an antiinflammatory drug.
    Gaetani M; Yamaguchi H; Vidi A; Hashimoto Y; Donetti A
    Pharmacol Res Commun; 1979 Sep; 11(8):719-30. PubMed ID: 515116
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of H2-receptor antagonists and imidazole on testosterone hydroxylations in mouse liver microsomes.
    Morita K; Ono K; Shimakawa H; Wada F
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4043-8. PubMed ID: 6152201
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic injury following feprazone therapy.
    Wiggins J; Scott DL
    Rheumatol Rehabil; 1981 Feb; 20(1):44-5. PubMed ID: 6452677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of drugs on steroid metabolism of rat liver microsomes].
    LEYBOLD K; STAUDINGER H
    Klin Wochenschr; 1961 Sep; 39():952-3. PubMed ID: 14464937
    [No Abstract]   [Full Text] [Related]  

  • 9. Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.
    Fletcher MR; Loebl W; Scott JT
    Ann Rheum Dis; 1975 Apr; 34(2):190-4. PubMed ID: 1094965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal blood loss on phenylbutazone and feprazone.
    Macfarlane JD; Maisey MN; Grahame R; Burry HC
    Rheumatol Rehabil; 1976 May; 15(2):108-11. PubMed ID: 132693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disposition of feprazone and its hydroxylated metabolite in human volunteers.
    Berry D; Parke DV
    Xenobiotica; 1988 Jul; 18(7):857-68. PubMed ID: 3176523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of feprazone and phenylbutazone interaction with warfarin in man.
    Chierichetti S; Bianchi G; Cerri B
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):568-72. PubMed ID: 810317
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of 1-substituted imidazole and 1,2,4-triazole antifungal compounds as inhibitors of testosterone hydroxylations catalysed by mouse hepatic microsomal cytochromes P-450.
    Ballard SA; Lodola A; Tarbit MH
    Biochem Pharmacol; 1988 Dec; 37(24):4643-51. PubMed ID: 3202901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind trial of feprazone and phenylbutazone in acute gout.
    Reardon JA; Stockman A; Darlington LG; Scott JT
    Curr Med Res Opin; 1980; 6(7):445-8. PubMed ID: 6988172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex- and age-dependent hydroxylations of testosterone in the liver of normally developed rats and in animals with disturbed sexual development.
    Ghraf R; Lax ER; Schriefers H
    Acta Endocrinol (Copenh); 1972 Dec; 71(4):781-91. PubMed ID: 4678213
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug.
    Koyama T; Izawa Y; Wada H; Makita T; Hashimoto Y; Enomoto M
    Toxicol Appl Pharmacol; 1982 Jun; 64(2):255-70. PubMed ID: 7123554
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of cannabinoids (delta9-THC and delta8-THC) on hepatic microsomal metabolism of testosterone in vitro.
    Chan MY; Tse A
    Biochem Pharmacol; 1978; 27(13):1725-8. PubMed ID: 708452
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombocytopenia and haemolytic anaemia due to feprazone.
    Bell PM; Humphrey CA
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):17. PubMed ID: 6797620
    [No Abstract]   [Full Text] [Related]  

  • 19. Rectal administration of feprazone in healthy volunteers.
    Ferrari P; Montanari C; Sala P; Vidi A
    Br J Clin Pharmacol; 1976 Apr; 3(2):339-40. PubMed ID: 973970
    [No Abstract]   [Full Text] [Related]  

  • 20. High-pressure liquid chromatographic feprazone determination in pharmaceutical formulations.
    Bonora A; Borea PA
    J Pharm Sci; 1979 Jun; 68(6):798-800. PubMed ID: 458589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.